ABSI
NASDAQ · Biotechnology
Absci Corp
$2.85
-0.16 (-5.32%)
Open$2.78
Previous Close$3.01
Day High$3.11
Day Low$2.78
52W High$5.23
52W Low$2.01
Volume—
Avg Volume4.34M
Market Cap463.14M
P/E Ratio—
EPS$-0.90
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+726.3% upside
Current
$2.85
$2.85
Target
$23.55
$23.55
$16.79
$23.55 avg
$35.63
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.24M | 6.35M | 58.57M |
| Net Income | -142,025,863 | -130,100,027 | -8,944,093 |
| Profit Margin | -2,274.1% | -2,160.4% | -15.3% |
| EBITDA | -122,710,467 | -118,651,342 | -15,160,350 |
| Free Cash Flow | — | — | -10,726,027 |
| Rev Growth | -1.8% | -1.8% | +10.3% |
| Debt/Equity | 0.02 | 0.02 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |